AG-270 |
AG-270 : Allosteric Inhibitor of MAT2A
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MAT2A |
|
|
Allosteric
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
<strong>Outside target family:</strong> assessment of AG-270 specificity in in vitro binding assa ...
Potency Cellular
In Vitro
MAT2A
Mode of Action: Allosteric
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.0c01895
In Vivo Validations
Mouse, Rat, Dog, Cyno
Dose: 10-200 mg/Kg
Route of delivery:
Oral
Plasma half life:
5.9 (M), 4.2 (R), 4.8 (C) 21.3 (D)
Systemic clearance:
0.0804 (M), 0.47 (R), 0.06 (C), 0.04 (D) L/h/Kg
Organ of interest (O):
Xenograft
Target engagement assay:
Led to dose-dependent reductions in tumor SAM levels and tumor growth of KP4 MTAP-null xenografts (TGI = 36% (10 mg/kg), 48% (30 mg/kg), 66% (100 mg/kg), 67% (200 mg/kg).
DOI Reference: 10.1021/acs.jmedchem.0c01895
Negative Control Compounds
Chemical Information
| Molecular Formula | C30H27N5O2 |
| SMILEs | COc1ccc(-c2c(Nc3ccccn3)[nH]c3c(C4=CCCCC4)c(-c4ccccc4)nn3c2=O)cc1 |
| InChI | InChI=1S/C30H27N5O2/c1-37-23-17-15-21(16-18-23)26-28(32-24-14-8-9-19-31-24)33-29-25(20-10-4-2-5-11-20)27(34-35(29)30(26)36)22-12-6-3-7-13-22/h3,6-10,12-19,33H,2,4-5,11H2,1H3,(H,31,32) |
| Molecular weight | 489.22 Da |
| AlogP | 6.461200000000005 |
| HBond acceptors | 7 |
| HBond donors | 2 |
| Atoms | 64 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.